Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index gains 1.80% in October (9.15% YTD)

Monday, November 18, 2013
Opalesque Industry Update - Hedge funds gained 1.80% in October, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 9.15% year to date.

“Investors correctly anticipated that a deal would be worked out to resolve the partial US government shutdown and debt ceiling debate," says Sol Waksman, founder and president of BarclayHedge.

Fifteen of Barclay’s 18 hedge fund indices had gains in October. Equity Long Bias gained 2.58%, European Equities were up 2.48%, Emerging Markets gained 2.22%, the Event Driven Index rose 2.11%, and Distressed Securities added 1.90%.

“Equity markets rallied again in October with the Euro Stoxx 50 Index gaining 6.04 percent and the S&P 500 rising 4.6 percent,” says Waksman.

“Although prices trended higher, 20 percent of the S&P 500 constituents posted losses and created greater dispersion of equity price movements and better trading opportunities for long/short managers.”

On the losing side, the Equity Short Bias Index was down 3.14% in October 2013, Technology slipped 0.11%, and Merger Arbitrage gave up 0.10%.

Year to date, the Healthcare & Biotechnology Index has gained 22.26%, Pacific Rim Equities are up 19.00%, the Equity Long Bias Index has gained 17.63%, Distressed Securities have returned 13.92%, and Equity Long/Short is up 10.70%.

The Equity Short Bias Index is down 23.78% in 2013, and is close to matching the 24.12% loss recorded in 2012.

The Barclay Fund of Funds Index gained 1.27% in October, and is up 6.15% year to date.

Press release

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its